Many hedge funds’ heady gains posted early in the year shriveled after the sector took a beating in the second quarter.
Content retrieved from: https://www.institutionalinvestor.com/article/2dj30ewe1nb6rlt2n1o8w/hedge-funds/8-knots-janus-henderson-and-casdin-capital-thrived-even-as-biotech-peers-suffered-a-reversal.
